Yearly mammography in women in their 40s with a medium familial risk of breast cancer can reduce the mortality rate by almost 30%, according to new research published online November 18 in Lancet.
The findings add more fuel to the heated clinical debate over whether screening mammography is really effective -- or necessary -- for women in the 40 to 50 age range.
Stephen Duffy, a professor of cancer screening at Barts and the London School of Medicine and Dentistry at Queen Mary, University of London, led a research team that conducted the Family History 01 (FH01) study exploring whether screening affects the disease stage and projected mortality of women younger than 50 who have a clinically significant family history of breast cancer.
The study included women from 76 centers across 34 cancer research networks in the U.K. who were enrolled between January 2003 and February 2007. It comprised a total of 6,710 women between the ages of 40 and 44 who received yearly mammography for a mean of four years up until November 2009.
Women with intermediate familial breast cancer risk were compared to a control group of participants from the U.K. Age Trial (106,971 women ages 40 to 42 years at recruitment and followed for 10 years) and a Dutch study of women between the ages of 25 and 77 with a family history of breast cancer diagnosed between 1980 and 2004.
Of the population, 136 women in the FH01 study were found to have breast cancer; 105 of these were diagnosed at screening, 28 were diagnosed due to symptoms in the screening interval, and three were diagnosed due to symptoms after failing to have their latest mammogram.
The study found a definite survival benefit to mammography screening: Women in the FH01 study had a predicted average 10-year survival of 81%, compared to 73% in the control group of the U.K. Age Trial and 71% in the Dutch study. The overall relative risk of patients in the FH01 study was 0.80 (95% confidence interval: 0.66-0.96).
After adjusting for underlying risk, the predicted 10-year mortality rate in the FH01 trial was up to 10%, compared to the control group from the U.K. Age Trial, which had a predicted 10-year mortality rate of up to 38%.
"Our data suggest that in women younger than 50 years who are at medium or greater familial risk of breast cancer, mammographic surveillance could increase cancer detection, reduce the risk of advanced stage disease, and decrease predicted mortality," the authors concluded.
By Kate Madden Yee
AuntMinnie.com staff writer
November 19, 2010
Related Reading
More frequent follow-up helps breast conservation patients, May 5, 2010
Breast MRI improves cancer staging for newly diagnosed women, May 3, 2010
Radiation exposure increases risk of breast cancer, March 4, 2010
DCIS recurrence rates higher in younger women, October 7, 2009
Women treated for DCIS are not obtaining regular surveillance mammograms, May 26, 2009
Copyright © 2010 AuntMinnie.com
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
